In 1832 Robiquet traced a shortfall in the morphine from Gregory's method to a new alkaline material, which he named codeine.
Reading Library · Anesthesia Epochs · 中文版
Watch the education video (for clinicians)
1832: Robiquet Names Codeine — Following a Discrepancy · Anesthesia Epochs Education Series

A method was said to yield more morphine, but Robiquet did not obtain the expected result when he repeated it. Before dismissing the method, he questioned the starting material: had the two investigators used different opium? That practical question became one route toward codeine in his report of 1832.[1, pp. 259–260]
The paper, “New Observations on the Principal Products of Opium,” did not begin by announcing a discovery. Robiquet explained that a much-studied material could still contain overlooked details. Differences between commercial samples and analytical methods complicated the investigation, and he narrowed his work to observations on particular products. This article follows the paper’s final section: how he pursued a discrepancy and named the material he obtained codéine. The date 1832 belongs to the publication; no precise experimental date has been established here.[1, title page, pp. 225–226, 259–267]
Begin with the same material
The Société de Pharmacie had asked Robiquet to examine a method proposed by William Gregory of Edinburgh. After his first disappointing repetition, he wrote to Gregory for a sample of the opium used. Gregory sent one. Robiquet divided it into two equal portions, using one to obtain the salt produced by Gregory’s method and the other to obtain morphine by the customary method.[1, pp. 259–260]

The mismatch remained. Robiquet suspected that the apparently white salt contained something else. After several checks, he made a further comparison: equal masses of Gregory’s salt and a salt prepared from what he described as very pure morphine, treated under the same conditions. They still yielded different amounts of morphine.[1, pp. 260–261]
These were two distinct comparisons—first addressing the starting material, then the two salts. They were chemical investigations, not controlled trials of therapeutic benefit. Nor did a white appearance settle what the material contained.
A clue in the remaining liquid
Robiquet enlarged the investigation and explicitly credited the young chemist Berthemot with carrying out that work. Near its end, the morphine recovered still did not account for the material as expected. Examination of the mother liquor together with the washings produced a crystalline material.[1, p. 261]
At first, Robiquet thought he had found meconine. Further examination, including the material’s alkaline character, challenged that interpretation. He continued its separation and purification and recorded its properties. Recognition unfolded through the investigation; codeine was not identified simply by seeing crystals.[1, pp. 262–263]

On page 264, Robiquet explicitly stated that he had named this material codéine. He discussed its ability to form salts and reactions that distinguished it from morphine; an elemental analysis followed. Those observations gave readers something to examine behind the name. They should not be rewritten as a modern determination of molecular structure. Nor is the separation sequence reproduced here as a preparation guide.[1, pp. 263–265]
An observation, followed by an “if”
Robiquet argued that the new material had been present in the opium before extraction. He also reported giving a sample to the young physician Kunckel and relayed physiological observations attributed to him. This establishes what Robiquet reported; Kunckel’s own account is not covered here and cannot count as a second, independent source.[1, pp. 266–267]

The ending mentioned harmful effects at larger amounts as well as the author’s hopes. Robiquet thought the material might help explain properties of opium not accounted for by morphine, but retained the condition “if this hope is realized.” Reducing the paper to the discovery of an effective, safe cough medicine or analgesic would exceed what it establishes.[1, pp. 266–267]
A specific comparison with Derosne’s 1803 opium memoir is also revealing. In the earlier passage, Derosne provisionally called his material a salt. Robiquet’s account presents the name codéine after further separation and comparison. The connection concerns how the two texts identify and name materials. It neither equates their substances nor asserts a direct influence between the authors.[1, pp. 262–265; 2, p. 280]
The date 1832 can therefore hold a more precise story than a discovery label: a sample received by correspondence, two comparisons, an acknowledged collaborator, and an expectation that still ended with a condition.
Sources and reading limits
- Robiquet. Nouvelles Observations sur les principaux Produits de l’Opium. Annales de chimie et de physique. 1832;51:225–267. Read: the introduction (pp. 225–226) and chapter IV (pp. 259–267), with the title page; pp. 227–258 are not covered. Kunckel’s own account is not covered.
- Derosne. Mémoire sur l’opium · Library copy. Annales de chimie. 1803;45:257–285. Page 280 is cited.
The 1803 and 1832 reports are discussed separately, each within a defined scope. All four images are original historical imaginings or modern editorial illustrations.
Continue exploring
Related reading connects shared questions and contexts; it does not by itself establish historical influence.
- 1803: Derosne's Opium Memoir Calls the Crystals a Salt
- 1817: Sertürner Publishes 'Ueber das Morphium'
- 1832: Liebig's Observations and Questions on Chloral
Anesthesia Epochs · The Source Room · About & Editorial Method
Updated October 30, 2026. Sources and reading limits are stated above. Illustrations are labelled as original source images or AI-made. Historical accounts are educational; they are not current treatment instructions.